BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 24285244)

  • 1. Intravital biobank and personalized cancer therapy: the correlation with omics.
    Luo J; Guo XR; Tang XJ; Sun XY; Yang ZS; Zhang Y; Dai LJ; Warnock GL
    Int J Cancer; 2014 Oct; 135(7):1511-6. PubMed ID: 24285244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omics techniques and biobanks to find new biomarkers for the early detection of acute lymphoblastic leukemia in middle-income countries: a perspective from Mexico.
    Aguirre-Guillén WA; Angeles-Floriano T; López-Martínez B; Reyes-Morales H; Zlotnik A; Valle-Rios R
    Bol Med Hosp Infant Mex; 2017; 74(3):227-232. PubMed ID: 29382491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of biobanks on research outcomes in rare diseases: a systematic review.
    Garcia M; Downs J; Russell A; Wang W
    Orphanet J Rare Dis; 2018 Nov; 13(1):202. PubMed ID: 30419920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biobanking for Personalized Medicine.
    Liu A; Pollard K
    Adv Exp Med Biol; 2015; 864():55-68. PubMed ID: 26420613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Quality Biobanks: Pivotal Assets for Reproducibility of OMICS-Data in Biomedical Translational Research.
    Dollé L; Bekaert S
    Proteomics; 2019 Nov; 19(21-22):e1800485. PubMed ID: 31321888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Japanese Biobanks: Current Status, Problems, and Future Challenges].
    Sueoka E
    Rinsho Byori; 2017 Feb; 65(2):190-198. PubMed ID: 30762986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-specific multi-omics models and the application in personalized combination therapy.
    John A; Qin B; Kalari KR; Wang L; Yu J
    Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
    Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
    Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liquid nitrogen biobank: a resource for biomedical research].
    Turchi S; Mercuri A; Lazzerini G; Chiesa MR; Musacchio L; Tozzi S; Boni M; Zirilli O; Andreassi MG
    Recenti Prog Med; 2012 Sep; 103(9):307-12. PubMed ID: 23023017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance in omics analyses of blood samples in long-term storage: opportunities for the exploitation of existing biobanks in environmental health research.
    Hebels DG; Georgiadis P; Keun HC; Athersuch TJ; Vineis P; Vermeulen R; Portengen L; Bergdahl IA; Hallmans G; Palli D; Bendinelli B; Krogh V; Tumino R; Sacerdote C; Panico S; Kleinjans JC; de Kok TM; Smith MT; Kyrtopoulos SA;
    Environ Health Perspect; 2013 Apr; 121(4):480-7. PubMed ID: 23384616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biobank bootstrapping: is biobank sustainability possible through cost recovery?
    Albert M; Bartlett J; Johnston RN; Schacter B; Watson P
    Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biobanking and the further development of precision medicine].
    Dahl E
    Pathologe; 2018 Jul; 39(4):308-312. PubMed ID: 29876651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The foundation of personalized medicine is the establishment of biobanks and their standardization.
    Policiuc L; Buse M; Gulei D; Andreea Zimta A; Braicu C; Iulia Irimie A; Berindan-Neagoe I
    J BUON; 2018; 23(3):550-560. PubMed ID: 30003718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biobanking: sample acquisition and quality assurance for 'omics' research.
    Yüzbaşıoğlu A; Özgüç M
    N Biotechnol; 2013 Mar; 30(3):339-42. PubMed ID: 23183539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE—.
    Yamaguchi K; Urakami K; Ohshima K; Mochizuki T; Akiyama Y; Uesaka K; Nakajima T; Takahashi M; Tamai S; Kusuhara M
    Biomed Res; 2014; 35(6):407-12. PubMed ID: 25743347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Omic Technologies in Alzheimer's Disease.
    Avramouli A; Vlamos PM
    Adv Exp Med Biol; 2017; 987():177-184. PubMed ID: 28971457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of Biobank Network in Japan].
    Ogishima S
    Gan To Kagaku Ryoho; 2022 Feb; 49(2):125-128. PubMed ID: 35249043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biobanks and personalized medicine.
    Olson JE; Bielinski SJ; Ryu E; Winkler EM; Takahashi PY; Pathak J; Cerhan JR
    Clin Genet; 2014 Jul; 86(1):50-5. PubMed ID: 24588254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.